Gerard Griffioen

Chief Tech/Sci/R&D Officer at

reMYND NV

Consumer Services

Commercial Services

Profile

Gerard Griffioen is currently the Chief Scientific Officer-Drug Discovery at reMYND NV.
He previously worked as a Principal at the University of Vienna and Katholieke Universiteit Leuven.
Dr. Griffioen obtained a doctorate degree from Vrije Universiteit Amsterdam in 1996.

Gerard Griffioen active positions

Companies	Position	Start
reMYND NV reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders	Chief Tech/Sci/R&D Officer	-

All active positions of Gerard Griffioen

Former positions of Gerard Griffioen

Companies	Position	End
Katholieke Universiteit Leuven Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
University of Vienna University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

See the detail of Gerard Griffioen's experience

Training of Gerard Griffioen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gerard Griffioen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Vienna University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Katholieke Universiteit Leuven Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
reMYND NV reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders	Commercial Services